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doi:10.1016/j.bjps.2010.01.026Summary Upper eyelid tumours, particularly basal cell carcinomas, are relatively frequent.
Surgical ablation of these lesions creates defects of variable complexity. Although several
options are available for lower eyelid reconstruction, fewer surgical alternatives exist for
upper eyelid reconstruction. Large defects of this region are usually reconstructed with
two-step procedures. In 1997, Okada et al. described a horizontal VeY myotarsocutaneous
advancement flap for reconstruction of a large upper eyelid defect in a single operative time.
However, no further studies were published regarding the use of this particular flap in upper
eyelid reconstruction. In addition, this flap is not described in most plastic surgery textbooks.
The authors report here their experience of 16 cases of horizontal VeY myotarsocutaneous
advancement flaps used to reconstruct full-thickness defects of the upper eyelid after tumour
excision. The tumour histological types were as follows: 12 basal cell carcinomas, 2 cases of
squamous cell carcinomas, 1 case of sebaceous cell carcinoma and 1 of malignant melanoma.
This technique allowed closure of defects of up to 60% of the eyelid width. None of the flaps
suffered necrosis. Themean operative timewas 30 min. No additional procedureswere necessary
as good functional and cosmetic results were achieved in all cases. No recurrences were noted.
In this series, the horizontal VeY myotarsocutaneous advancement flap proved to be a techni-
cally simple, reliable and expeditious option for reconstruction of full-thickness upper eyelid
defects (aswide as 60% of the eyelidwidth) in a single operative procedure. In the future this tech-
nique may become the preferential option for such defects.
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Figure 1 Case 1. Initial markings of surgical excision of
a squamous cell carcinoma of the upper eyelid margin in a 60-
year-old man. The VeY myotarsocutaneous flap skin incisions
are also marked, extending laterally into the crow’s feet area.
2014 J. Rosa et al.By far, the most common cause of eyelid defects is excision
of tumours.1e3Post upper eyelid tumour ablation, direct
repair is possible of defects of up to 30% of eyelid width in
younger patients, and up to 40% of the eyelid width in older
patients who have eyelid skin laxity.4 However, for larger
defects, either local flaps or grafts are required. These
options frequently fail to achieve an excellent cosmetic
outcome as the thin and mobile skin of the upper eyelid is
substantially different from that encountered in other body
areas. Moreover, the relative scarcity of redundant tissue in
the abutting regions of the upper eyelid can make mobi-
lisation of significant amounts of tissue into this area
a significant challenge5 and often demands a two-step
reconstructive procedure.1
In recent times, several authors have emphasised the
use of several flaps intrinsic to the upper eyelid6e10 so as to
circumvent these problems. In 1997, Okada et al. described
a horizontal VeY myotarsocutaneous advancement flap for
upper eyelid reconstruction, purportedly with several
advantages over traditional surgical options.7 However, inFigure 2 Case 1. (Left [Figure 2a]) The resulting defect repres
horizontal V to Y myotarsocutaneous flap is raised based on the u
(Right [Figure 2b]) The flap is mobilised into the defect, allowing fthe literature review conducted by us, we failed to
encounter further reports on the use of this particular type
of flap. In fact, this flap is not even mentioned either in
recent textbooks on facial plastic surgery and oculoplastic
surgery or in newer articles on eyelid reconstruction.1,11
Patients and methods
From January 2000 through May 2009, 16 patients with
locally advanced malignant tumours of the upper eyelid
underwent surgical resection by the senior author. Most of
these tumours (12) were basal cell carcinomas. There were
also two cases of squamous cell carcinomas, one case of
sebaceous cell carcinoma and one of malignant melanoma.
The resections had curative intent, resulting in upper
eyelid full-thickness defects ranging from 40% to 60% of
eyelid width. There were nine women and seven men. The
patients ranged from 45 to 78 years, with a mean age value
of 62.3. The follow-up varied from 2 months to 5 years, and
was 25 months on average.
After excision, the surgical specimen was sent to the
pathology laboratory and was assessed by both gross
examination and microscopical observation of fresh-frozen
sections. Only after the pathologist’s concordance was the
planned reconstruction undertaken.
The surgical defects were rectified with a horizontal
VeY myotarsocutaneous advancement flap similar to the
one originally described in 1997 by Okada et al.7 The flap
was based on the lateral cantal region, with the medial
portion corresponding to the height of the lateral border of
the defect. The flap extended laterally into the crow’s feet
area where it ended in an acute angle. The superior border
corresponded to the line of the superior palpebral fold. The
inferior margin continued till the inferior limit of the eye-
lid’s defect. The height-to-width ratio was approximately
1:3 to 1:4, resulting in a relatively long flap.
First, the superficial incisions were made till the level of
the orbicular muscle in the upper eyelid and the subcuta-
neous tissue at the lateral cantal region. After upper eyelid
eversion with a Desmarres retractor, an incision through the
eyelid conjunctiva and tarsal plate was made at the level of
the superior palpebral fold. At this stage, a V-shapedents approximately 40% of the original width of the eyelid. A
pper orbicular muscle and lateral orbital subcutaneous tissue.
or closure.
Figure 3 Case 1. One year after surgery, no recurrence is observed. Eyelid function is normal. Scars are inconspicuous and easily
confused with the lateral cantal wrinkles.
Upper eyelid reconstruction 2015myotarsocutaneous flap pedicled at the superior orbicular
muscle was created. It is worth mentioning that the trick-
iest part in elevating the flap was achieving the right depth
of dissection, as very superficial incisions would compro-
mise the flap’s excursion, whereas incisions through the
muscle might jeopardise the flap’s viability. The flap was
then mobilised horizontally with the help of a gentle pull
pressure exerted through a skin hook placed on its medial
border. To increase the excursion, a gentle blunt dissection
was performed at the lateral aspect of the flap incisions. At
times it was necessary to divide some fibrous connections in
that region. To promote horizontal sliding of tissues and
closing of the defect without tension, a lateral cantotomy
was performed when necessary.
The flap was sutured in two layers after alignment with
the eyelid-free margin. The tarsus and conjunctiva were
sutured with a simple running suture with a 6/0 resorbable
Monosyn. On the skin, either interrupted stitches or
a simple running suture with a 6/0 nylon were used. The
cutaneous stitches were removed between 5 to 7 days post-
operatively.Figure 4 Case 2. A 72-year-old woman with a sebaceous cell
carcinoma of the upper eyelid is prepared for wide surgical
excision of the lesion. The skin incisions for a long and wide
horizontal V to Y myotarsocutaneous flap are drawn.For each patient, the authors evaluated the following
criteria: demographic features, duration of the recon-
structive procedure, surgical complications, tumour
recurrence and the functional and aesthetical results
obtained. Patient satisfaction with the procedure was also
recorded.
Results
In all patients in whom the horizontal VeY myotarsocuta-
neous flap was used, the closure of the defect was achieved
in an expeditious manner and in a single surgery. None of
the flaps showed any signs of necrosis. Most patients had
transient periorbital oedema and bruising in the first few
days after surgery but these subsided rapidly.
The reconstructive procedure took an average operating
time of 30 min (ranging from 20 to 45 min).
No revision surgeries were deemed necessary as all
patients showed a stable upper eyelid with acceptable
motility and adequate corneal protection, including the
blink reflex.
No recurrences were observed.
From a cosmetic point of view, results ranged from
satisfactory to excellent in all patients. The incisions used
became unremarkable and easily merged with natural
wrinkles and folds at a rapid pace.




A 60-year-old man presented with a squamous cell carci-
noma of the lateral half of the upper eyelid (Figure 1).
The tumour was resected with a 5 mm margin. The
resulting defect was repaired by means of a horizontal
VeY myotarsocutaneous flap (Figure 2). One year after
surgery, no recurrence was observed and the patient
showed a good functional and aesthetic result (Figure 3).
In fact, even though the surgical scars were somewhat
visible, they were mistaken for the natural wrinkles in the
crow’s feet area.
Figure 5 Case 2. (Left [Figure 5a]) The surgical specimen is approximately 2cm wide, representing around 60% of the upper
eyelid width. (Right [Figure 5b]) Photograph taken at the end of the reconstructive procedure. The V to Y flap was mobilised into
the defect. A medial advancement flap was created to facilitate closure without tension or distortion of upper eyelid morphology.
2016 J. Rosa et al.Case 2
A 72-year-old woman presented with a sebaceous cell
carcinoma of the middle portion of the upper eyelid
(Figure 4). The tumour was resected with a 5 mm margin,
resulting in the excision of a 2 cm-wide surgical specimen
(Figure 5) and a defect of approximately 60% of the original
eyelid width. The defect was closed with a long horizontal
VeY myotarsocutaneous flap (Figure 5). To facilitate
closure and prevent eyelid deformation, a medial
advancement flap was also performed. One year after
surgery, no recurrence of disease was observed. Moreover,
an excellent functional and aesthetic result was obtained,
with the surgical scars being close to invisible (Figure 6).Discussion
As far as we could determine, the first description of VeY
flaps in facial reconstruction dates back to 1965.12 The first
example of this kind of flap being used in eyelid recon-
struction was published by Zook et al. in 1980.13 In this
article the authors reported the use of a VeY vertical
cutaneous flap in a patient for lower eyelid reconstruction.Figure 6 Case 2. One year after surgery, no recurrence or impai
confused with age-related wrinkles. A good aesthetic result was aIn 1989, Doermann et al. presented a series of 22 patients in
whom reconstruction of lower eyelid defects after tumour
ablation was achieved with VeY vertical myocutaneous
flaps.14
In 1988, lower eyelid reconstruction with a horizontal
VeY myocutaneous flap was described in the book Surgery
of Basal Cell Carcinoma of the Face, based on the experi-
ence of the authors with this technique in the preceding
years.15 More reports of horizontal VeY flap for lower
eyelid reconstruction were later published in 1996 by Kalus
and Zamora,16 and more recently by Marchac et al.10
Literature on the use of VeY flaps in upper eyelid
reconstruction is, however, much scarcer, which is
undoubtedly related to the fact that eyelid tumours are
much more frequent in the lower eyelid.1e3 In fact, it was
not until 1997 that Okada et al. described for the first time
a VeY horizontal myotarsocutaneous flap for reconstruction
of the upper eyelid in a patient with an eyelid tumour.
Subsequently, other authors have described the use of
vertical VeY myocutaneous flaps for upper eyelid recon-
struction after oncological surgery5,17 and reported a good
functional and aesthetic outcome in all patients.
Our data strongly support the view that the horizontal
VeY myotarsocutaneous flap presents several significantrment of eyelid function are observed. Surgical scars are easily
chieved.
Upper eyelid reconstruction 2017advantages, relatively, over other methods of reconstruc-
tion of the upper eyelid. To start with, it allows recon-
struction of significant defects in a single surgical
procedure, avoiding the morbidity, inconvenience and cost
of multiple surgical procedures. Also, being relatively easy
to perform, it demands a short operating time. In addition,
it does not require surgical intervention on the contra-
lateral eyelids or the lid margin of the ipsilateral lower lid,
leaving these areas untouched so that they can be used for
future reconstructive procedures if the tumour recurs.
The functional result is optimised by the fact that the
levator muscle remains attached to the reconstructed
upper eyelid, thus not compromising eyelid opening. In
addition, as the orbicular muscle is not sectioned, eyelid
closure and the blink reflex are also preserved.
From an aesthetic point of view, the horizontal VeY
myotarsocutaneous flap also achieves good results as it uses
ideally coloured and textured thin skin for reconstruction.
Moreover, the associated surgical scars become relatively
inconspicuous because they are placed in natural wrinkles
and folds, and because the areas involved in the recon-
struction heal well in most circumstances.
Consequently, the horizontal VeY myotarsocutaneous
flap, regardless of whether it is associated to lateral can-
totomy or not, seems suitable for the expeditious repair of
full-thickness upper eyelid defects involving 25e60% of the
upper eyelid. It is our strong belief that, in the future, this
technique may well become the preferential reconstructive
option in this context.
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